Hint mode is switched on Switch off

XBI - SPDR S&P Biotech ETF (USD) (US78464A8707)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

FIND, SAVE & TRACK INVESTMENTS WITH CBONDS WATCHLIST

With Cbonds Watchlist you can always stay updated on your investments to make conscious decisions!

Watchlist
You need to request access

Choose all Reset all
 
(%)
US78464A8707
XBI ISIN
Exchange Traded Funds (ETF)
Type of fund
SPDR State Street Global Advisors
Provider
158.06 USD
NAV per Share | 11/08/2026
31/01/2006
Inception Date
4 times per year
Dividend payments
CEOILS
CFI
XBI
Ticker
Formed
Status
Equity
Investment category
Biotech
Sector
USA
Investor locations
S&P Biotechnology Select Industry Index
Benchmark
0.35 %
Total Cost Ratio
10,423.88 mln USD
Fund NAV | 11/08/2026
10,423.88 mln USD
Share Class NAV | 11/08/2026
No
UCITS
1 / 3 (11/09/2015)
Split
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Unlock data Watch full tour

Yield on 12/08/2026, NYSE Arca

  • YTD
    5.06 %
  • 1M
    -7.93 %
  • 3M
    1.65 %
  • 6M
    11.2 %
  • 1Y
    62.15 %
  • 3Y
    51.47 %
  • 5Y
    0.91 %
  • 10Y
    143.19 %
At the price on the exchange, taking into account income payments

Latest data on
Add to compare
from
to
ADD-IN
Cbonds add-in API
bond data api

Quotes (XBI)

Explore the most comprehensive database

1 000 000

bonds

100 000

stocks

175 910

ETF & Funds

100 000

indices

Track your portfolio in the most efficient way

  • Bond Search
  • Watchlist
  • Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 1 000 000 bonds, 100 000 stocks, 100 000 indices, 17 000 ETF and 150 000 Mutual Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 1M bonds, 100K stocks, 100K indices, 17K ETF and 150K Mutual Funds
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Price dynamics

Fund profile

The SPDR S&P Biotech ETF seeks to replicate as closely as possible the price and yield performance of the S&P Biotechnology Select Industry Index by investing in a portfolio comprised primarily of U.S. companies in the biotechnology sector

XBI profile

The SPDR S&P Biotech ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The SPDR State Street Global Advisors fund’s base currency is USD and the share class was registered 31.01.2006 with unique ISIN - US78464A8707. Main exchange is NYSE Arca and ticker symbol is XBI. The total expense ratio is 0.35%. The SPDR S&P Biotech ETF (USD) pays dividends 4 time(s) per year.

Structure XBI on 11/08/2026

Download structure in Excel
Paper Value
TWIST BIOSCIENCE CORP 1.72%
ORUKA THERAPEUTICS INC 1.55%
APOGEE THERAPEUTICS INC 1.54%
PRAXIS PRECISION MEDICINES I 1.46%
HALOZYME THERAPEUTICS INC 1.38%
NATERA INC 1.37%
INSMED INC 1.36%
REVOLUTION MEDICINES INC 1.35%
DIANTHUS THERAPEUTICS INC 1.34%
CG ONCOLOGY INC 1.33%
PROTAGONIST THERAPEUTICS INC 1.33%
KYMERA THERAPEUTICS INC 1.32%
ERASCA INC 1.29%
SPYRE THERAPEUTICS INC 1.29%
REGENERON PHARMACEUTICALS 1.25%
MODERNA INC 1.24%
RHYTHM PHARMACEUTICALS INC 1.24%
VAXCYTE INC 1.23%
TRAVERE THERAPEUTICS INC 1.22%
RELAY THERAPEUTICS INC 1.2%
ARROWHEAD PHARMACEUTICALS IN 1.19%
BRIDGEBIO PHARMA INC 1.17%
ROIVANT SCIENCES LTD 1.17%
BIOMARIN PHARMACEUTICAL INC 1.17%
COGENT BIOSCIENCES INC 1.17%
AMGEN INC 1.16%
VIKING THERAPEUTICS INC 1.15%
VERTEX PHARMACEUTICALS INC 1.15%
SCHOLAR ROCK HOLDING CORP 1.12%
ACADIA PHARMACEUTICALS INC 1.11%
INCYTE CORP 1.09%
CYTOKINETICS INC 1.08%
MADRIGAL PHARMACEUTICALS INC 1.07%
SUMMIT THERAPEUTICS INC 1.07%
ALKERMES PLC 1.06%
GILEAD SCIENCES INC 1.06%
DYNE THERAPEUTICS INC 1.05%
ABBVIE INC 1.05%
CRISPR THERAPEUTICS AG 1.03%
UNIQURE NV 1.02%
GRAIL INC 1.02%
TG THERAPEUTICS INC 1.01%
IMMUNOVANT INC 1%
BIOGEN INC 0.99%
KRYSTAL BIOTECH INC 0.99%
MIRUM PHARMACEUTICALS INC 0.99%
NEUROCRINE BIOSCIENCES INC 0.95%
PTC THERAPEUTICS INC 0.95%
CELCUITY INC 0.94%
BIOCRYST PHARMACEUTICALS INC 0.94%
ULTRAGENYX PHARMACEUTICAL IN 0.94%
EXELIXIS INC 0.92%
SELLAS LIFE SCIENCES GROUP I 0.91%
IMMUNITYBIO INC 0.9%
UNITED THERAPEUTICS CORP 0.9%
IOVANCE BIOTHERAPEUTICS INC 0.9%
BEAM THERAPEUTICS INC 0.86%
VIRIDIAN THERAPEUTICS INC 0.86%
CELLDEX THERAPEUTICS INC 0.85%
DENALI THERAPEUTICS INC 0.81%
IDEAYA BIOSCIENCES INC 0.81%
SAREPTA THERAPEUTICS INC 0.77%
VERA THERAPEUTICS INC 0.76%
IMMUNOME INC 0.75%
DISC MEDICINE INC 0.74%
ADMA BIOLOGICS INC 0.73%
MINERALYS THERAPEUTICS INC 0.73%
ARCUTIS BIOTHERAPEUTICS INC 0.73%
TANGO THERAPEUTICS INC 0.72%
ALNYLAM PHARMACEUTICALS INC 0.72%
IONIS PHARMACEUTICALS INC 0.71%
ARCUS BIOSCIENCES INC 0.71%
RECURSION PHARMACEUTICALS A 0.7%
SYNDAX PHARMACEUTICALS INC 0.68%
VERACYTE INC 0.66%
INTELLIA THERAPEUTICS INC 0.66%
AGIOS PHARMACEUTICALS INC 0.62%
NURIX THERAPEUTICS INC 0.61%
PALVELLA THERAPEUTICS INC 0.6%
KODIAK SCIENCES INC 0.6%
NOVAVAX INC 0.57%
BIOHAVEN LTD 0.52%
CAREDX INC 0.51%
VERICEL CORP 0.5%
STOKE THERAPEUTICS INC 0.49%
ABSCI CORP 0.46%
PRECIGEN INC 0.46%
CULLINAN THERAPEUTICS INC 0.44%
ANAPTYSBIO INC 0.43%
ORIC PHARMACEUTICALS INC 0.43%
VIR BIOTECHNOLOGY INC 0.42%
ZENAS BIOPHARMA INC 0.42%
FIRST TRACKS BIOTHERAPEUTICS 0.41%
CORVUS PHARMACEUTICALS INC 0.41%
XENCOR INC 0.41%
HYPERLIQUID STRATEGIES 0.4%
VOR BIOPHARMA INC 0.39%
AVALO THERAPEUTICS INC 0.38%
REPLIMUNE GROUP INC 0.36%
TAYSHA GENE THERAPIES INC 0.35%
Show more Hide
Other - %

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Other ETF & Funds from this provider

Similar ETF & Funds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} mln
    NAV
    {{ item.expense_ratio }}
    Total Cost Ratio
Registration is required to get access.